Long-term effects on vascular healing of bare metal stents delivered via paclitaxel-coated balloons in the porcine model of restenosis

Background Clinical trials have consistently demonstrated benefits of Paclitaxel‐coated balloons (PCB) in particular clinical situations such as in‐stent restenosis and peripheral vascular interventions. However, the long‐term vascular effects of bare metal stents (BMS) delivered via PCB (PCB+BMS) a...

Full description

Saved in:
Bibliographic Details
Published inCatheterization and cardiovascular interventions Vol. 80; no. 4; pp. 603 - 610
Main Authors Cremers, Bodo, Milewski, Krzysztof, Clever, Yvonne P., Aboodi, Michael S., Biedermann, Melanie, Thim, Troels, Kelsch, Bettina, Kaluza, Greg L., Scheller, Bruno, Granada, Juan F.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.10.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Clinical trials have consistently demonstrated benefits of Paclitaxel‐coated balloons (PCB) in particular clinical situations such as in‐stent restenosis and peripheral vascular interventions. However, the long‐term vascular effects of bare metal stents (BMS) delivered via PCB (PCB+BMS) are still unknown. The aim of this study was to assess the long‐term effects of PCB+BMS on vascular healing and neointimal formation (NF). Methods A total of 208 stents: 56 BMS crimped on PCB, 50 BMS crimped on uncoated balloons (UCB+BMS), 52 Taxus and 50 Cypher stents were implanted in normal coronary arteries of 104 pigs using 1.2:1.0 stent‐to‐artery ratio. Follow‐up occurred at 3, 7, 28, 90, and 180 days. Vascular effects were assessed based on angiographic and histological analysis. Endothelialization was evaluated using an anti von‐Willebrand Factor stain. Results At 28 days, delivery of a BMS using a PCB led to a significant reduction in NF compared to the UCB+BMS and the Taxus stent (P < 0.01). Between 28 and 180 days, the progression of NF tended to be lower in the PCB+BMS compared to all DES groups. At 90 days, the PCB+BMS (2.56 ± 0.43) and the Taxus stents (2.60 ± 0.59) had a trend toward higher inflammatory scores compared to the UCB+BMS group (1.85 ± 1.13, P = 0.09). By 180 days, inflammation and NF had completely normalized between the groups. Expression of peristrut vWF was comparable among all tested groups at 28 days. Conclusion The long‐term pattern of vascular healing occurring following PCB+BMS deployment appears to be comparable to what has been reported with DES technologies. © 2012 Wiley Periodicals, Inc.
Bibliography:Bayer Schering Pharma, Berlin, Germany
Conflict of interest: Nothing to report.
ark:/67375/WNG-VZQMBGRZ-H
istex:15D8E1473E0E840CA1364205AA0C47A8D10425A2
ArticleID:CCD24305
Bodo Cremers and Krzysztof Milewski contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1522-1946
1522-726X
DOI:10.1002/ccd.24305